Daily Stock List
Tautachrome, Inc. (TTCM)
We are highlighting Tautachrome, Inc. (TTCM) today, here at the QualityStocks Daily Newsletter.
Tautachrome, Inc. is an Internet technology development enterprise headquartered in Oro Valley, Arizona. The Company’s main priority is developing its branded KlickZie platform. This platform will turn smartphones into trusted imagers. This means the pictures and videos they capture can be verified as original, untampered, and un-photoshopped. A Delaware corporation, Tautachrome’s shares trade on the OTC Markets Group’s OTCQB.
Tautachrome has operations in the U.S. and Australia. The Company has leading-edge patents pending. These include Talk-to-the-Picture social networking and the aforementioned trustable imagery-based interaction. Moreover, the KlickZie platform creates imagery that is interactive and engageable. Through clicking or tapping on a KlickZie'd image, users can communicate with the image's author or others currently looking at the image, in an engaging way. The KlickZie platform will serve as the world’s first imagery-based social website network.
Fundamentally, KlickZie is an image verification service for smartphones. It brings trust back to digital imagery. Also, KlickZie turns the smartphone into a reliable image source. Smartphone users download KlickZie’s free software to take their pictures and videos. KlickZie pictures and videos are invisibly marked, stored in the KlickZie cloud, and guaranteed free from manipulation. The cloud will certify the authenticity of any KlickZie picture or video.
At the beginning of this month, Tautachrome announced the issuance of its wholly-owned US Patent number 9,582,843. This is an important KlickZie technology patent targeted at the authentication of smartphone imagery from a Tautachrome managed Authentication Centric Entity (ACE) KlickZie cloud.
The Company’s authentication patent is the first of four KlickZie patents pending to issue. The other three patents pending encompass code protection inside the smartphone and Tautachrome’s “touch to talk” technology, which will reside partly in the smartphone and partly in the KlickZie cloud.
Yesterday, Tautachrome updated its fundraising activities and its continuing talks with a Fortune 50 company. The Company is meeting this week with an individual who is highly influential in Silicon Valley for guidance and potential participation in Silicon-Valley-sourced funding from venture capital firms and from potential KlickZie end users among the smartphone corporations in phone manufacturing, chip making, as well as service provision.
At the same time, Tautachrome continues its work this week with the first Fortune 50 company (F50-1) with whom it started working early this quarter on a concept to implement KlickZie trusted imaging end-to-end in this large corporation.
Tautachrome, Inc. (TTCM), closed Wednesday's trading session at $0.024, up 8.11%, on 1,128,809 volume with 38 trades. The average volume for the last 60 days is 1,037,310 and the stock's 52-week low/high is $0.0013/$0.0348.
EXOlifestyle, Inc. (EXOL)
The Observer and Promotion Stock Secrets reported earlier on EXOlifestyle, Inc. (EXOL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
EXOlifestyle, Inc. is a management organization that develops and operates unique and healthy brands within the health & wellness industry. The Company has a strong emphasis on athletic gear and apparel. Development of EXO was by experienced Crossfit Athletes who were looking for better training products, specifically knee sleeves.
EXOlifestyle is based in Boca Raton, Florida. The Company lists on the OTCQB. EXOlifestyle is primarily focused on its EXO, Inc. subsidiary, a designer and producer of active wear brands offered in national fitness retailers in the United States.
EXOlifestyle’s corporate mission is to provide a quality, functional and stylish knee sleeve that will stand up to its athletes’ training and competition protocol, every day. The Company’s intention is that its carefully manufactured products will enhance sport performance and muscle recovery for every athlete who puts on an Exo Sleeve.
Anti-microbial material is in Exo Sleeves. This significantly decreases the ability of microorganisms to grow on the surface of the material. As a result, this creates a longer use for the athlete, and a healthier way to train.
Features of Exo Sleeves include pull on support and relief from arthritis, bursitis and tendonitis; specialized flat stitch technology that provides a flatter, cleaner and stronger seam; and seamless back-of-knee and anatomical design for added comfort.
Additionally, features include latex-free neoprene that provides thermal/compression therapy. Furthermore, Exo Sleeves regulate body temperature; the outer heavy-duty nylon fabric is for durability; and the design is to enhance sport performance and muscle recovery.
The Company’s compression knee sleeve collection comes in an assortment of custom prints and colorful patterns. EXOlifestyle products also include knee wraps, wrist wraps and weight belts targeted to the high-performance athletic market.
This past December, EXOlifestyle announced that it is launching an online store on Amazon Marketplace (AMZN). EXOlifestyle is currently selling its signature compression knee sleeves. The Company will be launching its new line of wrist wraps online with the strength of the Amazon Marketplace behind them.
EXOlifestyle’s plans include expanding the fits, styles and colors of its present offerings, and also expanding its offerings to multiple price points. The Company has customers in Canada, Mexico, the UK, UAE, New Zealand and Australia. It expects to expand its efforts in these countries in Q3 2017, along with Spain, France, Italy and Germany. During Q2 of fiscal 2018, its plans include introducing its products to the Asian markets.
EXOlifestyle, Inc. (EXOL), closed Wednesday's trading session at $0.0076, up 1.33%, on 642,455 volume with 9 trades. The average volume for the last 60 days is 580,558 and the stock's 52-week low/high is $0.0068/$0.40.
PetroShare Corp. (PRHR)
DreamTeamNetwork and SmallCapVoice reported earlier on PetroShare Corp. (PRHR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
PetroShare Corp. is a domestic oil and natural gas exploration and development company. It targets capital deployment opportunities in established unconventional resource plays. The Company formed to investigate, acquire, and develop oil and gas properties in the Rocky Mountain and mid-continent regions of the United States. The Company’s present focus is in the Niobrara/Codell formations and adjacent oil and gas producing zones in the Rocky Mountain region. Specific targets are in the Wattenberg field within the DJ Basin of northeast Colorado. PetroShare is headquartered in Centennial, Colorado.
PetroShare is expanding its collection of properties through organic drilling and development, in addition to strategic acquisitions and joint ventures (JVs). The Company’s properties include Todd Creek Farms (Southern Wattenberg Field, NE Colorado; Niobrara and Codell Oil and Gas Development).
PetroShare acquired an initial acreage position of about 1280 gross acres (333 net acres) in the core of the oil dominated Niobrara/Codell resource development fairway in the southern end of the Greater Wattenberg Field area of NE Colorado.
Additionally, its properties include the Buck Peak Prospect (Sand Wash Basin, NW Colorado; Niobrara Oil Development). This Prospect is 7,700 gross acres (1,000 net acres) positioned in Moffat County. PetroShare has drilled and completed two producing wells in this prospect. The Buck Peak Prospect targets oil and associated wet gas from the fractured Niobrara Shale formation.
PetroShare announced, in September of last year, the signing of a Binding Letter of Intent (LOI) to acquire 305 net acres of leases adjacent to its Todd Creek Farms prospect area in Adams County, Colorado. The new leases potentially add up to 32 gross, standard and extended-length horizontal locations to its drilling inventory. In October, PetroShare completed the acquisition of additional royalty interests in 10 Jacobucci pad horizontal wells situated on its Todd Creek Farms prospect. This increases its net revenue interest in each well by an average of approximately 1.15 percent.
PetroShare has closed the previously announced Purchase and Sale Agreement with a third party for producing vertical wells and associated leases totaling around 15,514 gross (11,218 net) acres located primarily in Adams and Weld Counties, Colorado. The purchase price was $5.1 Million in cash after adjustments for product inventory and suspense accounts.
At the end of February, PetroShare announced that it entered into a Purchase and Sale Agreement with an independent third party seller to acquire oil and gas leases totaling roughly 5,879 gross (2,930 net) acres, with an average net revenue interest of 84 percent, positioned in Weld and Adams Counties, Colorado. The purchase price for the leases and associated assets is $2.582 Million.
PetroShare’s strategic partner and lender is Providence Energy Operators, LLC. Providence has agreed to purchase a 50 percent interest in the assets, decreasing the Company’s interest in the Agreement to 1,465 net acres. It will pay roughly $460,000 in cash and issue 450,000 shares of its common stock to the seller for its 50 percent share of the acquisition.
PetroShare Corp. (PRHR), closed Wednesday's trading session at $1.8924, even for the day. The average volume for the last 60 days is 4,033 and the stock's 52-week low/high is $0.66/$2.00.
eWellness Healthcare Corp. (EWLL)
Penny Stock Prodigy and StockHideout reported earlier on eWellness Healthcare Corp. (EWLL), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
OTCQB-listed, eWellness Healthcare Corp. develops a telemedicine platform. This platform is for providing Distance Monitored Physical Therapy programs. These programs are for pre-diabetic, cardiac, and health challenged patients through contracted physician practices and healthcare systems. The Company has launched PHZIO. The design of this telemedicine platform is to extend and scale a physician’s practice. eWellness Healthcare has its corporate headquarters in Culver City, California.
The Company is the first physical therapy telemedicine company to provide insurance reimbursable real-time distance monitored treatments. Its business model is to license its PHZIO platform to any physical therapy (PT) clinic in the U.S. and/or have large-scale employers use its PHZIO platform as an entirely PT monitored corporate wellness program.
eWellness Healthcare’s PHZIO is a Physical Therapy Telemedicine platform. It extends a traditional practice online. The principal features of the PHZIO platform include video treatment protocols, real-time patient monitoring, patient induction forms, a patient video journal, and post treatment evaluations. Moreover, principal features include integrated billing, patient metrics, as well as user administration & customization.
PHZIO also scales a practice’s billable rates. It also provides tools to make growing a business easier. Regarding the Patient Dashboard, the PHZIO Dashboard enables clients to login securely to access prescribed treatment protocols. PHZIO is user-friendly and highly reliable to operate for PT and Patient. Also, it’s a complete on-line PT telemedicine intervention system.
eWellness Healthcare announced, on October 21, 2016, that it successfully held its commercial launch of its PHZIO PT telemedicine intervention system as a Tier 1 sponsor of the American Physical Therapy Association (APTA), Private Practice Section (PPS) Annual Conference held in Las Vegas, Nevada.
eWellness Healthcare has launched a new PHZIO PT clinic on-boarding website. The site includes a telehealth profitability calculator to illustrate to prospective PT clinics the additional profits they can make through using the PHZIO platform.
This month, eWellness Healthcare announced that it anticipates starting onboarding and training physical therapists (PT's) in New York during the week of March 27, 2017 on its PHZIO platform. The onboarding and training is initially for a well-known Brooklyn based PT clinic owned by Motion PT Group. The Brooklyn-based clinic is one of more than 45 clinics presently owned by Motion PT Group. Motion PT’s initial PHZIO license is just for its Brooklyn location. However, the Company anticipates that all of Motion PT clinics may eventually treat patients employing eWellness Healthcare’s PHZIO platform.
Yesterday, eWellness Healthcare announced that its plan is to create a New York based regional sales, onboarding, and training team to support PT’s clinics in the states of New York, New Jersey, Connecticut, Massachusetts, Maryland, Pennsylvania and Virginia by mid-May 2017 for its PHZIO platform.
eWellness Healthcare Corp. (EWLL), closed Wednesday's trading session at $0.101, down 7.11%, on 579,465 volume with 58 trades. The average volume for the last 60 days is 542,136 and the stock's 52-week low/high is $0.0057/$4.00.
Noble Roman's, Inc. (NROM)
Marketbeat, The Bowser Report, TaglichBrothers, StockOodles, Wall Street Resources, FeedBlitz, and SmallCapVoice reported earlier on Noble Roman's, Inc. (NROM), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. The Company’s business model comprises three growth venues: Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising. Noble Roman's franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, Tuscano’s Italian Style Subs, and Noble Roman's Craft Pizza & Pub trade names. The Company is based in Indianapolis, Indiana.
Noble Roman's has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. The Company has also awarded franchise and/or license agreements in Puerto Rico, the Bahamas, Italy, Canada and the Dominican Republic.
Grocery Take-n-Bake Licensing involves licensing of individual Groceries to sell
Noble Roman’s Pizza. This is a component program using Noble Roman’s ingredients, in which delis assemble pizzas from standard Noble Roman’s ingredients.
Regarding Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the types of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.
Pertaining to Non-Traditional Venues, these are typically situated in a host facility whose primary business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit. Example kinds of locations include Convenience Stores; Walmart®/Retail Centers;
Entertainment Facilities; Bowling Centers; Hospitals; as well as Military Bases.
Noble Roman's announced in October 2016 that it signed an agreement with TMC Franchise Corp. (TMC) to become a Preferred Supplier for their system of franchised Circle K®, Kangaroo Express® and On the Run® convenience store brands in the United States. This totals roughly 800 locations.
TMC is part of the Alimentation Couche-Tard, Inc. group. Alimentation is one of the largest operators and franchisors of convenience stores in North America. TMC will communicate Noble Roman's preferred status for pizza-centered foodservice to its existing franchisees and to all new franchise prospects.
Last month, Noble Roman's announced that it opened its first location for its new-generation, stand-alone pizzeria concept called “Noble Roman's Craft Pizza & Pub”. The initial location opened in 4,000 square feet of the newly constructed Monon Marketplace on Main Street/Highway 32 across from Grand Park in Westfield, Indiana.
Noble Roman's Craft Pizza & Pub features two styles of hand-crafted, made-from-scratch pizzas with a selection of 40 different toppings, cheeses, and sauces. Additionally, beer and wine is featured, with 16 different beers on tap. This includes national and local craft selections. Wines include 16 high quality, affordably priced selections by the bottle or glass in a range of varietals. Beer and wine service is provided at the bar and throughout the dining room.
Last month, Noble Roman's announced that the first of its new-generation, stand-alone pizzerias (Noble Roman's Craft Pizza & Pub) surpassed its opening week net sales target by 53 percent. Opening January 31, 2017, the first seven days’ net sales volume was $38,283 in comparison to a projected opening volume of $25,000. Total gross sales before grand opening promotional discounts was $41,796.
Noble Roman's, Inc. (NROM), closed Wednesday's trading session at $0.535, down 7.76%, on 8,200 volume with 4 trades. The average volume for the last 60 days is 64,305 and the stock's 52-week low/high is $0.3562/$0.895.
One Step Vending Corp. (KOSK)
The QualityStocks Daily Newsletter would like to spotlight One Step Vending Corp. (KOSK). Today, One Step Vending Corp. closed trading at $0.0225, up 2.74%, on 480,243 volume with 60 trades. The stock’s average daily volume over the past 60 days is 1,057,173, and its 52-week low/high is $0.0026/$0.17.
One Step Vending Corp. (KOSK) is focused on growing through acquisitions and cooperative agreements with companies that have potential and capabilities of achieving sustainable growth and rapidly capturing market share. The company provides financing and operational business support while also helping build key growth strategies. Key business sectors actively targeted include food and refreshment services, self-checkout systems and mobile vending machines.
Corporate Refreshment Services Micro Markets Inc., a subsidiary of One Step Vending, is a self-checkout retailer that offers a wide range of food and beverages. With more than 150,000 units supplied to customers in the last twelve months, the company is experiencing triple-digit growth. Regardless if a traditional vending machine or the high-tech micro market is chosen, the location's patrons enjoy gourmet market deliciousness and quick market convenience.
Mainly targeting the office environment, the micro markets offer a fresh market-grab and go-food concept that doesn't cost the business anything to host. Each micro market can be customized for any size or look and feature an easy-to-use touch screen interface so anyone can easily shop, scan and pay for their items. Once installed, employees benefit from a diverse menu that includes healthy snacks, real food, classic vending favorites and much more.
The team behind this concept has been committed to staying at the forefront of vending technology for 15 years. By replacing traditional vending machines with micro markets, they experienced up to five times greater revenue in large accounts. Today, the groundwork is laid with unique capabilities and proven execution strategies.
With Corporate Refreshment Services setting the example, One Step Vending's mission is to support thousands of businesses in the realization of their business goals by delivering experiences that enrich and nourish. Fostering a winning network of associates and partners and building mutually loyalty and trust is core to the company's growth strategy. Disclaimer
One Step Vending Corp. Company Blog
One Step Vending Corp. News:
One Step Vending Corp. Installs Micro Market at Cushman Wakefield
One Step Vending Corp. Seeks Savvy Corporate Partners and Micro Market Investors for Mutually Beneficial Sales Growth Opportunities
One Step Vending Corp. Adds 18 Micro Market Locations in Six Weeks with Continued Accelerated Growth Expected
InMed Pharmaceuticals, Inc. (IMLFF)
The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.284, up 1.07%, on 876,031 volume with 289 trades. The stock’s average daily volume over the past 60 days is 831,376, and its 52-week low/high is $0.05/$0.4261.
CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing InMed Pharmaceuticals Inc.'s (CSE: IN) (OTCQB: IMLFF) exceptional management team and their unique approach to the market. The cannabis plant has been used for centuries for its therapeutic benefits, but researchers have only recently started to take a commercial interest in the plant. While the drug discovery process can be a billion dollar endeavor, there are some companies working on more efficient solutions to bring safe and effective cannabinoid-based drugs to market.
InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.
Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”
After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.
The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.
INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.
InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.
The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.
Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.
Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer
InMed Pharmaceuticals, Inc. Company Blog
InMed Pharmaceuticals, Inc. News:
InMed's Exceptional Management Team Executes Ambitious Plan -- CFN Media
NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use
InMed Pharmaceuticals Files PCT Patent for Epidermolysis Bullosa Simplex
Singlepoint, Inc. (SING)
The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0525, up 21.53%, on 4,988,663 volume with 396 trades. The stock’s average daily volume over the past 60 days is 9,779,549, and its 52-week low/high is $0.0055/$0.142.
Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.
SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.
SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.
As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer
Singlepoint, Inc. Company Blog
Singlepoint, Inc. News:
NetworkNewsBreaks – Singlepoint, Inc. (SING) CEO Discusses Convectium Acquisition in Interview on MoneyTV
SinglePoint Executes on Cannabis Acquisition Strategy -- CFN Media
Greg Lambrecht, CEO of SinglePoint Inc., Discusses Recent SING News and Industry Trends in A New Audio Interview withSmallCapVoice.com
MGX Minerals, Inc. (MGXMF)
The QualityStocks Daily Newsletter would like to spotlight MGX Minerals, Inc. (MGXMF). Today, MGX Minerals, Inc. closed trading at $2.99, up 4.55%, on 24,700 volume with 23 trades. The stock’s average daily volume over the past 60 days is 153,444, and its 52-week low/high is $0.11/$2.119.
MGX Minerals, Inc. (MGXMF) a diversified mining company based in Vancouver, holds asset portfolios in lithium, magnesium, and silicon in western Canada, with a stated focus on the development of industrial mineral portfolios in specific commodities and jurisdictions offering near-term production potential, minimal barriers to entry, and low initial capital expenditures. Targeting properties where large-scale development opportunities exist, they prefer to acquire regional control in mineral properties to enhance portfolio value, and engage industry experts to mitigate execution risk and improve time to market.
Positive developments have made the company's lithium operations a special point of interest. An important factor is the company's engineering partner Purlucid Treatment Solutions, which has developed technologies representing a major step in the process of extracting lithium from petroleum brine water (petrolithium). MGX already holds the largest lithium portfolio in Canada, with its Sturgeon Lake property in Alberta and other lithium assets, and the company is the sole proprietary technology holder for processing petrolithium. Purlucid has now successfully demonstrated a way to upgrade brine samples from 67mg/L of lithium to 1600mg/L of lithium, while at the same time removing all magnesium, boron, and potassium. This significant pre-processing achievement, generating solutions 1200 percent higher than anticipated, can be expected to have an impact on the cost of production for the entire petrolithium process, since, according to Purlucid CEO Dr. Preston McEachern, the "biggest challenge in lithium recovery is creating a clean brine."
MGX and Purlucid together are already in the bulk sample and pilot plant design optimization phase of development in preparation for deployment, progressing toward unlocking their calculated 2 million metric ton lithium carbonate resource. The initial petrolithium pilot plant is projected to process 12,000 liters of brine per day, and management now sees a future plant capable of handling over a million liters of brine per day. It can be reasonable that future plants will be located near a major operation's water collection and reinjection sites, complete with available infrastructure already in place. Using a current conservative price of $12,000 per metric ton, and the potential to produce upwards of 14,000 metric tons of lithium carbonate per year, the potential from just one major plant would be revenues of nearly $170 million annually.
Additionally, MGX Minerals holds the sole legal patent on the petrolithium process across North America, and is now planning operations in Utah, near the emerging Gigafactory underway by Tesla, with its anticipated demand for lithium. The company believes there is a virtually endless source of lithium-bearing brines in North America.
Supporting this is the company's operations with silicon and magnesium. MGX Minerals controls three high-grade silicon projects in British Columbia. There are currently no producers of silicon in western North America, and the company is evaluating the economic viability of producing silicon metal from high-purity quartzite. MGX is also now developing North America's next magnesium oxide mine in central British Columbia, a location with good mineralization and excellent infrastructure. Disclaimer
MGX Minerals, Inc. Company Blog
MGX Minerals, Inc. News:
MGX Minerals Reports Advancement of Lithium Filtration Technology - 1600mg/L Li Concentrate from 67 mg/L Li Petro Lithium Brine
MGX Minerals Announces CA$5 Million Private Placement Financing
MGX Minerals Acquires Lisbon Valley Petro Lithium Project in Utah
India Globalization Capital, Inc. (IGC)
The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital, Inc. (NYSE: IGC). Today, India Globalization Capital, Inc. closed trading at $0.42, up 0.10%, on 174,517 volume with 371 trades. The stock’s average daily volume over the past 60 days is 196,188, and its 52-week low/high is $0.19/$0.6701.
India Globalization Capital, Inc. (IGC) is a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions.
The national cost of health care due to pain ranges from $560 billion to $635 billion. In addition, the health care cost attributed to the abuse of prescription opioids, closely related to pain, is approximately $25 billion. IGC's patent filing (IGC-501) is a cannabis-based formulation addressing neuropathic and arthritic pain in joints and muscles using a variety of delivery techniques. The Company anticipates commencing clinical trials, and hopes that through its focus on combination therapy it can formulate and commercialize cannabinoid compounds as an alternative to long-term addictive opioid treatments.
The Company has also filed combination therapy formulations for the treatment of epilepsy and cachexia. About 50 million people worldwide are affected by epilepsy and about 1.3 million in the U.S. experience cachexia associated with cancer, MS, Parkinson's, HIV/AIDS and other progressive illnesses. Cancer-induced anorexia/cachexia is responsible for 20% of all cancer deaths. IGC-502 indicated for seizures and IGC-504 indicated for cachexia are unique combination therapies that, if proven out by clinical trials, are expected to treat medical refractory epilepsy and eating disorders respectively, with lower side effects than conventional mono therapies.
IGC's strategy is exciting and unique in that it is aiming to become a leader in the phytocannabinoid-based combination therapy specialty pharmaceutical sector. This first mover advantage can potentially be formidable as it begins clinical trials and further builds its patent portfolio. "The development of combination therapies utilizing cannabis represents a large, unique opportunity in this emerging specialty-pharmaceutical sector. Securing FDA approval for combination therapy is believed to be significantly faster and less expensive than new drug applications. As a result, we believe that we can bring our cannabis-based pharmaceutical products to market in both an expeditious and cost-effective manner," stated Ram Mukunda, CEO.
IGC has recently exited its legacy businesses and currently holds international investments in land and in a hotel project. An impressive and experienced team, led by Mr. Ram Mukunda, CEO, directs IGC.
Mr. Mukunda holds degrees in Electrical Engineering and Mathematics from the University of Maryland (UMD). He founded and served as Chairman and CEO of Startec Global Communications, an international telecommunications carrier focused on providing voice over Internet protocol (VOIP) services to emerging economies. Startec, the first pure play international long distance carrier, went public on NASDAQ. He has won a number of awards, including the 2013 University of Maryland International Alumnus of the year award. Mr. Mukunda serves as an Emeritus member on the Board of Visitors at the University of Maryland, School of Engineering, and has served as Council Member at Harvard's Kennedy School of Government, Belfer Center of Science and International Affairs. Mr. Mukunda and Dr. Krishna are the originators of all the IGC patent filings.
Dr. Ranga Krishna, Senior Advisor, is a Board Certified Neurologist with a sub specialty in Epilepsy surgery. He is the Director of Neurology at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College and the Director of Stroke Service at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College. He is the Medical Director and Chairman of Total Neuro Care, P.C. He is CEO of International Pharma Trials, Inc., which assists U.S. pharmaceutical companies perform Phase II clinical trials. Dr. Krishna is a member of several organizations, including the American Academy of Neurology and the Medical Society of the State of New York. He is also a member of the Medical Arbitration panel for the New York State Workers' Compensation Board and a Founding Member of the New York State Pain Society. Dr. Krishna was trained at New York's Mount Sinai Medical Center (1991-1994) and New York University (1994-1996). Dr. Krishna and Mr. Mukunda are the originators of all the IGC patent filings. Disclaimer
India Globalization Capital, Inc. Company Blog
India Globalization Capital, Inc. News:
IGC Files Patent for Cannabis-based Combination Therapy for Treatment of Eating Disorders
NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Benzinga Article
IGC Announces Third Quarter Financial Results
Today's Top 3
Penny Stock Titans
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- ChineseInvestors.com, Inc. (CIIX) SeeThruEquity Issues Update on ChineseInvestors.com, Increasing Price Target to $3.75
- Dominovas Energy Corp. (DNRG) Enters Formal Negotiations to Open in India and Indonesia
- eXp World Holdings, Inc. (EXPI) eXp Realty Reaches 3,000 Agent Milestone
- GreenStone Healthcare Corp. (GRST) Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida
- India Globalization Capital, Inc. (NYSE: IGC) Files Patent for Cannabis-based Combination Therapy for Treatment of Eating Disorders
- InMed Pharmaceuticals Inc. (IMLFF) NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use
- MGX Minerals Inc. (MGXMF) Reports Advancement of Lithium Filtration Technology - 1600mg/L Li Concentrate from 67 mg/L Li Petro Lithium Brine
- Monaker Group, Inc. (MKGI) to Present at the 29th Annual ROTH Conference, March 15, 2017
- National Waste Management Holdings, Inc. (NWMH) Expands Territory with Acquisition of Burts Refuse, LLC
- One Step Vending Corp. (KOSK) Installs Micro Market at Cushman Wakefield
- ORHub, Inc. (ORHB) NetworkNewsWire Announces Publication of Discussion on the Value of IT & Big Data Analytics for the Health Care Industry
- ProBility Media Corp. (PBYA) and GlobalSim Inc. Join Forces to Introduce Virtual Reality Training to the Crane Industry
- Players Network (OTCQB: PNTV) Featured on MoneyTV with Donald Baillargeon, 2/17
- Singlepoint, Inc. (SING) Executes on Cannabis Acquisition Strategy -- CFN Media
- Stealth Technologies, Inc. (STTH) Announces 5 New Products